.@georgezachary shares...
• How he met @elonmusk (his friend since the 90s)
• Backing Zip2 (Elon and @kimbal's company)
• What Seed investors were like in the '90s
Full Episode
: https://linktr.ee/twistartups pic.twitter.com/P5iVRxfkaY
-
Show this thread
-
Replying to @Jason @georgezachary and
FYI mayor
@Jason pay for performance sounds good in theory but only punishes those of us who work at safety-net hospitals and clinics already struggling to make ends meet because we serve the sickest, poorest and underserved "non-compliant" populations.1 reply 0 retweets 0 likes -
Replying to @grepmeded @Jason and
GrepMed Retweeted Syed Husain
It will only increase health disparities, keep surgeons from operating on sicker patients, etc. Here's one example of how perverse incentives encourage transplant centers to waste massive numbers of perfectly good donor kidneys every year:https://twitter.com/SAHusainMD/status/1215911979614949377 …
GrepMed added,
Syed Husain @SAHusainMD1/ Inspired by this exchange between@kidney_boy and@dreliotheher, here is my first ever#tweeetorial: the issues with the current#kidney allocation system in the U.S., based mainly on the work of@SumitMohanMD and Jesse Schold, and inspired by my jetlag#KidneyTransplant https://twitter.com/kidney_boy/status/1215100958654500865 …Show this thread1 reply 0 retweets 0 likes -
Replying to @grepmeded @Jason and
Absolutely do not fall for the full body MRI scam unless you are high risk of familial disease, some other condition warranting screening. For every feel good anecdote like
@georgezachary's, any experienced clinician has seen many more elective procedures and biopsies that have1 reply 0 retweets 0 likes -
Replying to @grepmeded @Jason and
led to major complications and eventual death. Hospitals are very dangerous places. These side effects of testing and treating false positives is why our best screening efforts have modest cancer-specific benefits but very little to no all-cause mortality benefit.
2 replies 0 retweets 0 likes -
You don't need that stress or potential for iatrogenic harm in your life- not until we develop much better tests that can distinguish the scary-benign lesions from the scary-scary lesions.
Otherwise another great episode- still my favorite podcast! 

Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.